Key facts
| Price (PPV) | 605 MAD |
|---|---|
| Dispensing status | Unscheduled — no prescription needed |
| Composition (DCI) | vaccin méningococcique conjugué des groupes aw et y |
| Class | Vaccines |
| ATC code | J07AH08 |
| Manufacturer | MAROC BIOTECHNOLOGIE MARBIO |
| Presentation | Boite d'un flacon uni-dose de 0,5 ml |
| Nature | Médicament |
| Hospital price | 402 MAD |
| Data collected on | 9/8/2026 |
Indications
MenQuadfi est indiqué pour l’immunisation active des sujets à partir de 12 mois contre les infections invasives à méningocoques dues aux Neisseria meningitidis des groupes A, C, W et Y. Ce vaccin doit être utilisé selon les recommandations officielles en vigueur
Find an open pharmacy
On-call pharmacies near you
About Menquadfi
Menquadfi belongs to the vaccines therapeutic class. In Morocco, this drug is marketed by MAROC BIOTECHNOLOGIE MARBIO and is among the pharmaceutical specialties referenced by the Ministry of Health.
For any question about the use, effects, or drug interactions of Menquadfi, consult your doctor or pharmacist. This information is provided for educational purposes and does not replace medical advice.
Frequently Asked Questions about Menquadfi
Answers to common questions from Moroccan patients about this drug.